M Bajaj, S Suraamornkul, T Pratipanawatr, LJ … - Diabetes, 2003 - Am Diabetes Assoc The effect of pioglitazone on splanchnic glucose uptake (SGU), endogenous
glucose production (EGP), and hepatic fat content was studied in 14 type 2
diabetic patients (age 50 ± 2 years, BMI 29.4 ± 1.1 kg/m 2 , HbA 1c 7.8 ... Cited by 165 - Related articles - BL Direct - All 4 versions
M Bajaj, S Suraamornkul, T Pratipanawatr, LJ … - Diabetes, 2003 - diabetezone.it Page 1. Pioglitazone riduce il contenuto epatico di grasso ed aumenta la captazione
di glucosio a livello splancnico nei pazienti con diabete di tipo 2. ... Related articles - View as HTML
AB Mayerson, RS Hundal, S Dufour, V Lebon, … - Diabetes, 2002 - Am Diabetes Assoc We examined the effect of three months of rosiglitazone treatment (4 mg bid) on
whole-body insulin sensitivity and in vivo peripheral adipocyte insulin
sensitivity as assessed by glycerol release in microdialysis from ... Cited by 418 - Related articles - BL Direct - All 4 versions
- ►endojournals.org Y Miyazaki, A Mahankali, M Matsuda, S … - Journal of Clinical Endocrinology & Metabolism, 2002 - Endocrine Soc We examined the effect of pioglitazone on abdominal fat distribution to
elucidate the mechanisms via which pioglitazone improves insulin resistance in
patients with type 2 diabetes mellitus. Thirteen type 2 diabetic patients ... Cited by 334 - Related articles - BL Direct - All 8 versions
DG Carey, GJ Cowin, GJ Galloway, NP Jones, … - Obesity, 2002 - nature.com Results: There was a significant improvement in glycemic control (glycosylated
hemoglobin -0.7 0.7%, p 0.05) and an 86% increase in insulin sensitivity in the
RSG group (glucose-disposal rate change from baseline: 17.5 14.5 mol ... Cited by 130 - Related articles - All 3 versions
M Tiikkainen, AM Häkkinen, E Korsheninnikova … - Diabetes, 2004 - Am Diabetes Assoc Both rosiglitazone and metformin increase hepatic insulin sensitivity, but their
mechanism of action has not been compared in humans. The objective of this study
was to compare the effects of rosiglitazone and metformin treatment on ... Cited by 276 - Related articles - BL Direct - All 6 versions
L Ryysy, AM Hakkinen, T Goto, S Vehkavaara, … - DIABETES-NEW YORK-, 2000 - Am Diabetes Assoc Page 1. DIABETES, VOL. 49, MAY 2000 749 Hepatic Fat Content and Insulin Action
on Free Fatty Acids and Glucose Metabolism Rather Than ... Cited by 210 - Related articles - BL Direct - All 7 versions
- ►endojournals.org M Bajaj, S Suraamornkul, P Piper, LJ Hardies … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc The effect of pioglitazone (PIO) on plasma adiponectin concentration, endogenous
glucose production (EGP), and hepatic fat content (HFC) was studied in 11 type 2
diabetic patients (age, 52 ± 2 yr; body mass index, 29.6 ± 1.1 kg/m 2 ; ... Cited by 211 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org Y Miyazaki, A Mahankali, M Matsuda, L Glass, … - Diabetes Care, 2001 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 23 diabetic patients (age 30–70
years, BMI < 36 kg/m 2 ) who were being treated with a stable dose of
sulfonylurea were randomly assigned to receive either placebo (n = 11) or ... Cited by 273 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org M Bajaj, T Pratipanawatr, R Berria, W … - Diabetes, 2002 - Am Diabetes Assoc Splanchnic glucose uptake (SGU) plays a major role in the disposal of an oral
glucose load (OGL). To investigate the effect of an elevated plasma free fatty
acid (FFA) concentration on SGU in patients with type 2 diabetes, we ... Cited by 14 - Related articles - BL Direct - All 6 versions
